A new treatment for advanced urothelial cancer was effective with tolerable side effects in an international, multi-center phase 2 clinical trial. The trial results prompted a U.S. Food and Drug Administration (FDA) accelerated approval of the treatment on April 13, giving patients with this very aggressive type of cancer a new therapeutic option.
source https://www.sciencedaily.com/releases/2021/08/210802160627.htm
Tuesday, 3 August 2021
Related Posts
Whooping cranes steer clear of wind turbines when selecting stopover sitesAn article reports that whooping cranes migrating through the U.S. Gre… Read More
Glaciers and enigmatic stone stripes in the Ethiopian highlandsAlthough past temperature variations in the tropics are of great impor… Read More
Scientists sketch aged star system using over a century of observationsAstronomers have painted their best picture yet of an RV Tauri variabl… Read More
Birds learn to avoid flashy, hard-to-catch butterflies and their lookalikesThe showy colors of some butterflies could advertise their speed and n… Read More
An unusual creature is coming out of winter's slumber: Here's why scientists are excitedAnimals that hibernate in the wild rarely do so in zoos and sanctuarie… Read More
Traces of Earth's early magma ocean identified in Greenland rocksNew research led by the University of Cambridge has found rare evidenc… Read More
0 comments: